ABSTRACT: The bacterial cell wall is essential to cell survival and is a major target of antibiotics. The main component of the bacterial cell wall is peptidoglycan, a cage-like macromolecule that preserves cellular integrity and maintains cell shape. The insolubility and heterogeneity of peptidoglycan pose a challenge to conventional structural analyses. Here we use solid-state NMR combined with specific isotopic labeling to probe a key structural feature of the Staphylococcus aureus peptidoglycan quantitatively and nondestructively. We observed that both the cell-wall morphology and the peptidoglycan structure are functions of growth stage in S. aureus synthetic medium (SASM). Specifically, S. aureus cells at stationary phase have thicker cell walls with nonuniformly thickened septa compared to cells in exponential phase, and remarkably, 12% (±2%) of the stems in their peptidoglycan do not have pentaglycine bridges attached. Mechanistically, we determined that these observations are triggered by the depletion of glycine in the nutrient medium, which is coincident with the start of the stationary phase, and that the production of the structurally altered peptidoglycan can be prevented by the addition of excess glycine. We also demonstrated that the structural changes primarily arise within newly synthesized peptidoglycan rather than through the modification of previously synthesized peptidoglycan. Collectively, our observations emphasize the plasticity in bacterial cell-wall assembly and the possibility to manipulate peptidoglycan structure with external stimuli.
Staphylococcus aureus is a Gram-positive pathogenic bacterium well-known for its virulence and antibiotic resistance, particularly to drugs such as penicillin, methicillin, and vancomycin, which target cell-wall biosynthesis. 1, 2 The major component of the bacterial cell wall is peptidoglycan, a cage-like polymer enveloping the cytoplasmic membrane to withstand the turgor pressure of the cell, maintain bacterial cell shape, and serve as a scaffold for other cell-wall components. 3 Its essential role in bacterial cell survival and its absence in human cells render the peptidoglycan a major target for antibiotics.
In S. aureus, peptidoglycan synthesis begins in the cytoplasm where the precursor Lipid II is assembled. Lipid II consists of the membrane-tethered disaccharide, (β-1,4) N-acetylglucosamine-N-acetylmuramic acid (GlcNAc-MurNAc), linked to a pentapeptide that is functionalized with a pentaglycine bridge attached to the ε-amino group of L-Lys. Lipid II is transported to the membrane exoface and is polymerized through transglycosylation (to extend the glycan chains) and transpeptidation (to cross-link the pentaglycine bridge to the D-Ala in position four of a neighboring stem), accompanied by release of the undecaprenyl pyrophosphate lipid tether. 4 The resulting polymer structure is shown in Figure 1 . The characteristic pentaglycine cross-linking motif of S. aureus introduces flexibility and, thus, enables an extremely high cross-linking density in the peptidoglycan, which contributes substantially to the stability of the cell wall. The pentaglycine bridge also serves as an anchor for surface protein attachment, 5, 6 an important determinant for pathogenicity. Shortening of the pentaglycine bridge has been shown to impair growth and reduce or even abolish methicillin resistance. 7, 8 Studies have demonstrated that the peptidoglycan chemical structure can change in response to environmental stimuli such as NaCl concentration, 9 D-amino acids, 10, 11 and antibiotics. 12 To date, most S. aureus peptidoglycan studies have focused on exponential phase cells. However, stationary phase cells are more relevant in the context of the persistent and biofilmassociated infections where currently available antibiotics exhibit reduced efficacy. 13−17 Thus, the physiology of bacteria in the stationary phase merits greater attention, and to this end, we address the possibility that structural variations in the S. aureus peptidoglycan may accompany changes in growth stage and nutrient status.
In the Gram-negative bacterium Escherichia coli, the growth stage has been correlated with changes in the peptidoglycan fine structure. 18, 19 In S. aureus, electron microscopy and AFM studies revealed that the cell walls of stationary phase cells (grown in BHI medium) are thicker and appear smoother relative to cells in exponential phase, 20, 21 but the peptidoglycan chemical structure has not been examined. Characterizing the chemical/fine structure of the peptidoglycan in S. aureus is more challenging than in E. coli due to the presence of a more highly cross-linked network. 22 Enzymatic digestions using muramidase, for example, and HPLC-MS analyses 23−26 can provide some valuable information about the composition of the peptidoglycan but does not provide a complete accounting of peptidoglycan components. In particular, the highly crosslinked muropeptide species that cannot be fully resolved often appear as a "hump" in HPLC chromatograms. 24 Recently, solidstate NMR has been applied on uniformly labeled peptidoglycan of E. coli, B. subtilis, and S. aureus with good resolution and has allowed the identification and assignment of the peptidoglycan monomers. 27, 28 On the other hand, a number of solid-state NMR studies have also been developed using specific labeling strategies to quantify and characterize peptidoglycan composition and architecture in both isolated peptidoglycan and in intact whole cells. 29−31 Using this approach, we describe a previously uncharacterized structural variation in the peptidoglycan of stationary phase S. aureus cells grown in S. aureus synthetic medium (SASM), and we further show that the depletion of glycine in the stationary phase culture is responsible for the observed structural changes.
■ MATERIALS AND METHODS
Growth and Labeling of S. aureus Whole Cells. S. aureus (ATCC 29213) were cultured in S. aureus synthetic Figure 1 . Staphylococcus aureus peptidoglycan. (a) Chemical structure of S. aureus peptidoglycan, which is cross-linked through an interpeptide bridge consisting of five glycines to connect the ε-amino group of L-Lys in the third position of one stem (bridge-link, highlighted) to the D-Ala in the fourth position of the connected stem (cross-link) with the concomitant cleavage of the terminal D-Ala. (b) Assembly pathway of S. aureus peptidoglycan. The peptidoglycan precursor lipid II is assembled inside the cell with the pentaglycine bridge attached and is "flipped" outside the cell to be incorporated into the peptidoglycan network through transglycosylation (to connect the glycan strands) and transpeptidation (to cross-link the peptides). 29 at 37°C with constant shaking at 200 rpm (Innova 4400 incubator shaker, New Brunswick Scientific). Overnight starter cultures were prepared by inoculating 2 mL of SASM with a single colony grown on trypticase soy agar. 300 mL preparative-scale growths were performed in 1 L flasks using a 1:300 (v/v) inoculum of an overnight starter culture. For the preparation of isotopically labeled samples, the naturalabundance amino acids in SASM were replaced by either L-[ε- C, 15 N]-lysine (Isotec, Sigma-Aldrich). The optical density at 660 nm was monitored with a Lambda 35 UV−vis spectrometer (Perkin-Elmer, Inc.). Cells were harvested at the specific OD 660 values as illustrated in Figure 2a by centrifugation at 10000g at 4°C for 10 min. Cell pellets were rinsed with icecold 5 mM Hepes buffer (pH 7) three times with centrifugation to remove labeled amino acids and then resuspended in 8 mL of lyophilization buffer (5 mM Hepes with 8 mM Trehalose, pH 7), frozen with liquid N 2 , and lyophilized (FreeZone 12, Labconco). Typical yields of whole cells were about 200 mg/L per an OD value of 1.0.
Isolation of Peptidoglycan. Peptidoglycan was isolated from lyophilized whole cells similarly as described before 29, 32 with some modifications to stringently remove unbroken whole cells. Typically, 200 mg of lyophilized whole cells were resuspended in 30 mL of ice-cold potassium phosphate butter (pH 7) with 2 mg of DNase I (type II from bovine pancreas, Sigma-Aldrich) and transferred to a 50 mL bead beater (Biospec Products, Bartlesville, OK) chamber which was twothirds filled with prechilled 0.1 mm zirconia/silica beads. Cells were repeatedly beat through 10 cycles of 1 min disruption and 1 min rest. After disruption, the homogenate and beads were filtered with a course glass-scintered filter to separate the homogenate (filtrate) from the beads by vacuum filtration. The beads were washed further with 100 mL of ice-cold EDTA (pH 7). The crude wall preparation was then collected by centrifuging the filtrate at 25000g (Sorvall SS-34 rotor), at 4°C for 30 min. The pellet was resuspended in 20 mL of ice-cold water, added dropwise to 100 mL of boiling 4% SDS, and was boiled for 30 min with constant stirring. The mixture was allowed to cool for 2 h with stirring and then stood unstirred overnight at room temperature. SDS was removed by centrifugation of the mixture at 38000g for 1 h at room temperature followed by four washes with 0.01 M Tris buffer (pH 8.2). The resulting pellet was then resuspended in 60 mL of 0.01 M Tris buffer (pH 8.2) containing 2 mg of DNase I and 8 mg of trypsin (type II-S from bovine pancreas, SigmaAldrich) and R-chymotrypsin (type II from bovine pancreas, Sigma-Aldrich) and incubated at 37°C with shaking (150 rpm) for 16 h. This mixture was centrifuged at 38000g for 1 h at room temperature and washed three times with Tris buffer with centrifugation after each rinse. The pellet was resuspended in 50 mL of Tris buffer and pelleted at 500g for 5 min to remove any unbroken cells or large cell debris and repeated three times until no further pellet was observed. Aliquots from each step in the isolation were analyzed by protein gel electrophoresis using 12% SDS-PAGE gels (Invitrogen) and staining with Coomassie Blue to assess the overall protein content of the samples. The purified peptidoglycan was collected by centrifugation at 38000g at RT for 1 h, resuspended in 4 mL of lyophilization buffer (5 mM Hepes with 8 mM Trehalose, pH 7.0), and lyophilized.
Additionally, for HPLC and LC-MS analysis, the isolated peptidoglycan samples were also treated with hydrofluoric acid (49%) at 4°C for 48 h to remove teichoic acid. The peptidoglycan was recovered by centrifugation and washed with water four times.
Fluorescence Microscopy. The isolated peptidoglycan was resuspended in phosphate buffered saline (PBS) to 0.2 mg/ mL and stained with 4′,6-diamidino-2-phenylindole (DAPI) (3 μM in PBS) for 10 min. The samples were examined by fluorescence microscopy on a thin pad of 1% agarose. Wholecell samples were prepared (OD 660 0.2) and examined the same way. All images were captured with a Nikon Ti-E microscope, 100× oil-immersion lens (NA = 1.40) using phase contrast, and a DU-885 cooled CCD camera (Andor) and μ-Manager software.
Solid-State NMR. All NMR experiments were performed with an 89 mm wide-bore Varian/Agilent magnet at 11.7 T (499.11 MHz for 1 H, 125.49 MHz for 13 C, and 50.58 MHz for 15 N), Varian console, and a home-built four-frequency transmission-line probe 33 with a 13.6 mm long, 6 mm inner diameter sample coil, and a Revolution NMR magic angle spinning Vespel stator. Samples were spun in thin-wall 5 mm outer diameter zirconia rotors (Revolution NMR, LLC) at 8 kHz ± 2 Hz, using a Varian MAS control unit. The temperature was controlled by a variable temperature stack (FTS systems Inc.) and maintained at 10°C. American Microwave Technology RF power pulse amplifiers (M3445B, 2 kW, Herley Inc.) were used to produce radio-frequency pulses for 15 N (50 MHz) and 13 C (125 MHz) while the 1 H (499 MHz) radio-frequency pulses were generated by 2 kW tube amplifiers (Amplifier System Inc., Herley Inc.) driven by a 50 W American Microwave Technology power amplifier (M3900C-2, Herley Inc.) under active control. 34 π pulse lengths were 10 μs for 13 C and 15 N for both CPMAS 35 and REDOR 36 experiments. Proton−carbon and proton−nitrogen matched cross-polarization transfers were at 50 kHz for 2 ms. The proton dipolar decoupling was applied at 83 kHz with a 2 s recycle delay. The chemical shift scale of the 13 C NMR spectra was referenced to external adamantane and that of the 15 N NMR spectra to external crystalline [1-13 C, 15 N]glycine. For quantification of amide and amine population in CPMAS spectra, the integral of each peak was obtained as a function of contact time and is extrapolated to zero contact time to account for the differences in rotating frame cross-polarization dynamics (relaxation during cross-polarization) between the amide and amine resonances.
Transmission Electron Microscopy. TEM was performed at the Stanford Cell Science Imaging Facility. Whole cell samples for ultrathin section TEM were grown in the same way as for NMR experiments and harvested at OD 660 values shown in Figure 2a . For each sample, an aliquot of culture was removed and fixed overnight in 2% glutaraldehyde and 4% paraformaldehyde at 4°C. The fixed samples were pelleted and washed in sodium cacodylate buffer three times to remove the excess fixative and resuspended in 20 μL of gelatin solution at 37°C. The suspensions were solidify on ice and then cut into ∼1 mm 3 blocks followed by postfixation in 1% OsO 4 at 4°C for 1 h. Samples were then washed with cold deionized H 2 O three times and stained with 1% uranyl acetate at 4°C overnight. Dehydration of samples was carried out in a gradient series of ethanol. Samples were then embedded in Epon. Ultrathin (80 nm) sections were made with a Leica Ultracut S microtome, stained with uranyl acetate and lead citrate, and viewed on a JEM-1400 (JEOL, LLC). Images were analyzed with ImageJ. Cells with nearly equatorial cuts were selected for cell wall and septum thickness measurements to avoid systematic errors due to the section positioning.
Negative staining TEM was conducted on isolated peptidoglycan of stationary phase cells. 10 μL of 1 mg/mL peptidoglycan in PBS was applied onto the carbon-coated copper grids (300 mesh) for 3 min and rinsed in deionized H 2 O. Each grid was then negatively stained with 2% uranyl acetate (dH 2 O) for 2 min and dried. The samples were examined with the same electron microscope as was used above.
HPLC and LC-MS. Digestion and analysis of peptidoglycan were carried out as described before 23, 24, 37 with some modifications. Peptidoglycan, normalized by OD 600 , was incubated with mutanolysin (Streptomyces globisporus, SigmaAldrich) in 12.5 mM phosphate buffer (pH 5.5) at 37°C for 16 h. Digested peptidoglycan samples were boiled for 10 min and centrifuged at 13000g for 10 min. Soluble material was mixed with an equal volume of 0.5 M sodium borate (pH 9) and reduced via the addition of 3−5 mg of sodium borohydride at room temp for 30 min. The reaction was inactivated by the addition of 20% phosphoric acid, and the final pH of the solution was adjusted to 2.
Reduced muropeptides were separated by HPLC on a 250 × 4.6 mm ODS hypersil 3 μm C18 column (Thermo Scientific) using an Agilent (Santa Clara, CA) 1100 column compartment, quarternary pump, autosampler, and UV detector. The column was eluted at a flow rate of 0.5 mL/min with a linear gradient starting 5 min after injection of 5% (v/v) methanol to 30% (v/ v) methanol in 100 mM NaH 2 PO 4 (pH 2.5) in 150 min. The column temperature was 52°C. The eluted compounds were detected by absorption at 206 nm.
For liquid chromatography mass spectrometry (LC-MS), HPLC was performed using an Agilent (Santa Clara, CA) 1100 column compartment, binary pump, autosampler, and UV detector on a Varian (Palo Alto, CA) Polaris 5u, C18-A column, 2.1 × 250 mm at ambient temperature. The flow rate was 0.25 mL/min with a gradient held for 4 min at 0% solvent B (acetonitrile with 0.1% formic acid) and 100% solvent A (0.1% formic acid in water) followed by a ramp from 0% B to 95% B in 30 min. Low-resolution mass spectrometric analyses were carried out on a Thermo-Fisher (San Jose, CA) LTQ XL Both peptidoglycan samples treated with and without hydrofluoric acid were analyzed and compared with HPLC and LC-MS ( Figure S1 and Table S2 ). The major features of the muropepetides discussed in this study are independent of the hydrofluoric acid treatment.
Solution NMR. All solution NMR experiments on media were acquired at the Stanford University Department of Chemistry NMR facility. 1D 1 H− 13 C HSQC spectra were acquired at 10°C on a Varian Inova 600 MHz spectrometer, equipped with a 5 mm triple-resonance 1 
H{
13 C, 15 N}, pulsefield gradient probe. 10% D 2 O was added to samples for locking and shimming. Experiments were recorded with an 8000 Hz spectral width and 4000 data points, F1 dimension ( 13 C) delay t 1 set to zero, 3 s recycle delay, and 256 scans. All HSQC data were processed in VNMRJ.
■ RESULTS
Cell-Wall Morphology Is a Function of Growth Stage in SASM.
We first evaluated changes in the cell-wall morphology at different growth stages of S. aureus strain 29213 grown in S. aureus synthetic medium (SASM). Ultrathin sections of S. aureus cells harvested at four different culture densities (monitored by OD 660 ) were examined by transmission electron microscopy (TEM). Obvious differences are observed as cells transition to stationary phase (Figure 2 ). The average cell-wall thickness increases by 25% (Figure 2b and Table 1) between exponential phase (OD 0.7) and stationary phase (OD 4). Furthermore, the septum thickness increases dramatically toward the stationary phase, and each septum exhibits a nonuniform distribution of the thickness across the septum starting at early stationary phasethicker toward the center and thinner toward the edges or cell surface (Figure 2c,d) . Specifically, from OD 0.7 to OD 4 the average septum thickness increases by 1-fold near the edges and 2-fold near the center (Table 1) .
Peptidoglycan Bridge-Link Density Is a Function of Growth Stage in SASM. To determine if there were any changes in the chemical structure of the peptidoglycan at different growth stages, we used solid-state NMR to quantify the populations of bridge-links in specifically labeled peptidoglycan. We have found that rigorous and quantitative examination of the peptidoglycan chemical structure in S. aureus requires a stringent peptidoglycan isolation protocol to ensure that the preparation is pure with no whole-cell contaminants that could contribute to the spectra of isolated peptidoglycan. DAPI staining (Figure 3a) and SDS-PAGE (data not shown) confirmed that no DNA or proteins from unbroken cells were present in our peptidoglycan preparations. Negative staining TEM also confirmed that the majority of the specimens were empty sacculi which remained mostly intact with the spherical shape of the cell and septum but without the cellular contents (Figure 3c ). pentaglycine bridge) in the peptidoglycan and among Lipid II precursors. The second peak, centered at 10 ppm, corresponds to the amine form of the lysine ε-amino group, which, in whole cells, harbors contributions from peptidoglycan precursors without pentaglycine bridges attached (i.e., Park's nucleotide, Lipid I, and immature Lipid II), from cellular proteins, and from free lysine in the cytoplasm. The absence of other nitrogen resonances, such as those from His, Arg, Gln, or Asn residues, indicates that no significant scrambling has occurred. In addition, 13 C{ 15 N}REDOR with a 1 ms mixing time, to select for one-bond 13 C− 15 N pairs, yields a REDOR difference spectrum (Figure 4b ) with only the two major peaks expected.
Specific labeling with L-[ε-
The carbonyl peak at 171 ppm corresponds to the Gly carbonyl that forms an amide bond with the Lys ε-N, and the second peak at 40 ppm is assigned to the Lys ε-C which is shift resolved from the α-carbons of other amino acids. 31, 38 These data demonstrate that the L-[ε-
15 N]lysine in SASM was incorporated specifically without detectable scrambling.
With these prerequisites satisfied, we examined the peptidoglycan bridge-link status as a function of growth stage. 15 N CPMAS spectra of the peptidoglycan isolated from L-[ε-
15 N]lysine-labeled cells harvested at four different growth stages were recorded, calibrated, and compared as shown in Figure 5 . In exponential phase (OD 0.7), only one peak at 95 ppm is present in the spectrum and is assigned to the amide form of Lys ε-N in a bridge-link with the pentaglycine bridge attached. However, starting from OD 2.0, where cells transition from the exponential phase to stationary phase, a second peak at 10 ppm emerges and grows larger toward OD 4 (stationary phase). As the purity of the peptidoglycan (Figure 3 ) and the specificity of the ε-15 N Lys label (Figure 4) were demonstrated, we assigned this peak to the amine form of the Lys ε-N in the peptidoglycan corresponding to stems without an attached bridge. This population of non-bridge-linked stems increases progressively as cells enter stationary phase and reaches a maximum value of 12% of all peptidoglycan stems at OD 4 (12 h growth, stationary phase).
HPLC and Mass Spectrometry Confirms the Presence of Non-Bridge-Linked Stems at Stationary Phase. To further characterize and compare the structural changes in peptidoglycan observed by solid-state NMR using the more commonly employed chromatographic and mass spectrometry methods on digested muropeptides, the peptidoglycan samples were treated with mutanolysin, which cleaves the MurNAc-(1→4)-GlcNAc linkage and releases the disaccharide muropeptides, and analyzed by reversed-phase HPLC. Additional peaks at early elution times (red dashed box in Figure 6a) were detected in the OD 4 peptidoglycan in comparison with the OD 2 peptidoglycan. These peaks have been observed in the peptidoglycan of S. aureus strain COL 24 and correspond to monomeric muropeptides without a bridge attached. Moreover, the "hump" originating from highly cross-linked muropeptides is smaller in the OD 4 peptidoglycan compared to that of OD 2, suggesting that the peptidoglycan of cells harvested at OD 4 is less cross-linked. This could be attributed to the increase in the number of non-bridge-linked stems, which cannot participate in cross-linking. Additional peaks in the HPLC chromatogram of the OD 4 peptidoglycan were also observed in the region associated with monomeric muropeptides with an 15 N CPMAS spectra of [ε- 15 N]Lys-labeled peptidoglycan isolated from S. aureus cells at OD 0.7, 2, 3.6, and 4 (from left to right). Spectra are normalized to the amide peak. The amine peak at 10 ppm starts to appear at OD 2.0 (not obvious) and grows toward OD 4 (stationary phase). Spectra were acquired using the same condition as in Figure 4 . attached pentaglycine bridge (approximate retention time of 40 min). Thus, there appear to be other bridge-linked variants that are produced in addition to the typical pentaglycine-bridged stems.
In order to confirm the presence of the specific monomeric muropeptides, the muropeptide mixture was also separated and analyzed by LC-MS method (HPLC-MS condition). The detected species of interest are summarized and intensities compared in Table 2 . The muropeptide with an m/z of 969.5 corresponds to the monomeric muropeptide with no bridge attached (GlcNAc-MurNAc-AQKAA) shown in Figure 6b and was detected as a major component in the OD 4 peptidoglycan sample, but only as a very minor component in the OD 2 peptidoglycan sample (the relative intensity of the signal based on peak area in the OD 4 peptidoglycan is ∼20 times higher than in the OD 2 peptidoglycan for the same concentration of peptidoglycan). Another related muropeptide with m/z = 898.5 (71 units less than the above-mentioned muropeptide) was detected in the OD 4 peptidoglycan and can be attributed to the same monomeric muropeptide with a loss of a D-Ala at the stem terminus (GlcNAc-MurNAc-AQKA). Interestingly, a muropeptide with m/z = 1040.5 (969.5 + 71) was also detected in the OD 4 peptidoglycan sample, indicating an additional alanine, which is consistent with an identification as GlcNAc-MurNAc-AQK(A)AA, a muropeptide species that has been observed in S. aureus peptidoglycan previously, 24 where an additional alanine is bonded to the ε-amino group of lysine.
Glycine Is Depleted as Cells Enter the Stationary Phase. We hypothesized that, mechanistically, the observations associated with growth stage could be the result of glycine depletion, particularly since the peptidoglycan amino acid composition is approximately 50% glycine and the major structural alteration observed was that of peptidoglycan stems without glycine bridges. Thus, we monitored the changes of a few nutrients during growth including glucose ( Figure S2 ) and glycine. The glycine content in the nutrient medium was monitored directly by solution NMR using [2- 13 C]glycinecontaining SASM. Briefly, cultures at designated growth stages (monitored by OD 660 ) were sterile filtered to remove the cells and analyzed with 1 H− 13 C HSQC to selectively detect [2- 13 C]glycine. The glycine region of the 13 C-selected 1 H NMR spectra obtained at each growth stage is shown in Figure  7a . The glycine level in SASM decreases as the culture grows and is significantly depleted starting at the early stationary phase (8 h growth in SASM) where the non-bridge-linked stems were first observed. This finding supports the possibility that the depletion of glycine at stationary phase causes S. aureus cells to produce the more glycine-deficient peptidoglycan.
Chemical Structure of Peptidoglycan Depends on Glycine Availability. To further test the hypothesis that the structural changes in the S. aureus peptidoglycan are caused by glycine depletion, we manipulated the glycine concentration in SASM and sought to decouple effects due to glycine from those due to the growth stage of the culture. We first eliminated glycine entirely from SASM. Growth in SASM without glycine is delayed by about 12 h, but the culture eventually reaches a similar final cell density as in the normal glycine(+) medium (Figure 8a, left) . The 15 N CPMAS spectrum of the peptidoglycan of cells harvested at OD 2 in the glycine(−) SASM labeled with L-[ε- 15 N]Lys contains an amine peak, corresponding to stems without bridges. The effect of glycine starvation is not as severe as might be expected, owing to the de novo synthesis of glycine from other nutrients. Nonetheless, the In addition to the glycine elimination experiment, we supplemented SASM with additional glycine to examine the influence on S. aureus peptidoglycan structure at the stationary phase. Media with various initial glycine concentrations were tested and the glycine level in each was monitored during growth by solution NMR. We found that SASM with eight times the usual glycine concentration (800 mg/L vs 100 mg/L) still has glycine available in the medium at stationary phase ( Figure S3 ). With this excess of glycine, the culture reaches a higher final cell density (Figure 8b , left) and exhibits a slight postponement in reaching the stationary phase. Remarkably, the amine peak corresponding to the non-bridge-linked stems (glycine-deficient peptidoglycan) in 8X glycine L-[ε-
15 N]lysinecontaining SASM is significantly suppressed at stationary phase, supporting the hypothesis that the availability of glycine allows for normal peptidoglycan assembly, while glycine deprivation is responsible for the synthesis of the structurally altered and glycine-deficient peptidoglycan.
Non-Bridge-Linked Stems (Glycine-Deficient Peptidoglycan) Are Newly Synthesized. In principle, the observed non-bridge-linked stems (glycine-deficient peptidoglycan) at stationary phase grown in SASM could either arise from direct synthesis of such stems or from the hydrolysis or modification of previously synthesized peptidoglycan (to potentially release glycine for other use). To distinguish between these two possibilities, cells were grown in L-[ε-
15 N]lysine-containing SASM, pulse labeled with L-[ε- 13 C, 15 N]lysine at early stationary phase (OD 3.6, 8 h growth), and harvested at later stationary phase (OD 4, 12 h growth) as indicated in Figure 9a . As shown in Figure 9a , the addition of L-[ε- 13 C, 15 N]lysine at early stationary phase does not affect the growth of S. aureus. N]lysine. If the structural changes were due to modification of existing peptidoglycan, then the relative amine peak to amide peak ratio in the pulse label L-[ε- 13 C, 15 N]Lys should be smaller than or at least comparable to that of the background label, L-[ε-
15 N]Lys, present from the start of growth. Yet, in the REDOR-selected 15 N spectrum, the amine peak corresponding to non-bridge-linked stems is more than 2 times greater in the ΔS spectrum than in S 0 spectrum, indicating that the non-bridge-linked stems are more highly enriched in the newly synthesized peptidoglycan. In addition, the pulse-labeled L-[ε-13 C, 15 N]Lys amines constitute 41% of the overall amine population (Figure 9b , ΔS/S 0 ), which corresponds to most of the newly emerged Lys ε-N amines since the total percentage of amines doubles from OD 3.6 (after 8 h growth) to OD 4 (after 12 h growth) ( Figure 5 and Table 1 ). Thus, these results suggest that the non-bridge-attached stems arise from altered synthesis rather than emerging as the result of modification or hydrolysis of existing peptidoglycan.
■ DISCUSSION
We have identified and characterized a structural variation in S. aureus peptidoglycan that we first observed in the stationary phase of cells grown in SASM, implementing both solid-state NMR on intact sacculi and HPLC-MS on digested muropeptides. We found that, along with having thickened cell walls and nonuniformly thickened septa, the peptidoglycan of S. aureus cells harvested at stationary phase (grown in SASM) harbors non-bridge-linked stems and is thus less cross-linked. NMR permitted the quantification of these changes, which is not possible using the HPLC-MS methods due to the highly crosslinked peptidoglycan, evidenced by the high molecular weight "hump", that cannot be resolved in the HPLC chromatogram. Furthermore, we demonstrated that the depletion of glycine that coincides with the start of the stationary phase, when grown in SASM, is responsible for the observed structural changes in SASM and that supplementing glycine could significantly suppress the emergence of non-bridge-linked stems. Thus, the structural alteration is not a direct response to growth stage but appears to be triggered by the depletion of glycine in a medium which originally contained a sufficient glycine concentration to permit normal cell growth. This observation is consistent with the high demand for glycine in S. aureus peptidoglycan biosynthesis, particularly as cells grow to high cell densities and glycine becomes limiting.
Interestingly, high concentrations of exogenous glycine (4.5 g/L or more) added to rich media (TSB) can result in the assembly of peptidoglycan in which glycine is incorporated into the peptidoglycan in place of the terminal D-Ala. 39 Since stems ending in D-Ala-Gly, rather than D-Ala-D-Ala, are poor substrates for enzymes involved in peptidoglycan assembly, this glycine modification lowers the degree of cross-linking, and 30 g/L of exogenously added glycine can even inhibit cell-wall synthesis and thus cell growth. 40 Our pulse labeling experiment indicates that the non-bridgelinked stems (resulting in glycine-deficient peptidoglycan) predominantly arise from newly synthesized peptidoglycan as opposed to the postsynthetic modification of previously synthesized peptidoglycan. In addition, no hydrolase in S. aureus, to the best of our knowledge, has been reported to cleave peptidoglycan at the Gly-(ε-N)Lys bridge-link site, 37, 41 supporting the hypothesis that these peptidoglycan units are transported across the cell membrane as un-bridge-linked stems, rather than emerging as the result of potential cleavage of the Gly-(ε-N)Lys bond outside the cell. It is also known that in spherical cells such as S. aureus new peptidoglycan is inserted only at the division septum. 42 Thus, our results are consistent with a model in which the nonuniformly thickened septa observed by microscopy may result from the newly synthesized glycine-deficient and less cross-linked peptidoglycan.
In summary, our data suggest that S. aureus can make and survive with "imperfect" peptidoglycan when glycine is depleted in the stationary phase. It is surprising that S. aureus is able to harbor a significant amount (12%) of non-bridge-linked stems in its peptidoglycan given the importance of the interpeptide pentaglycine bridge, where a FemX mutant (complete deletion of the bridge) is known to be lethal. 8 Instead of pausing or slowing down the peptidoglycan biosynthesis during glycine starvation to coordinate with glycine synthesis to assemble canonical peptidoglycan, S. aureus produces glycine-deficient peptidoglycan and possibly compensates by increasing peptidoglycan thickness. These structural alterations were observed during growth in a commonly employed nutrient medium, and bacteria are likely to encounter similar nutrient limitation in the natural environment as well as in the host. Our findings emphasize the plasticity in S. aureus peptidoglycan assembly and inspire efforts to develop new strategies to manipulate and interfere with cell-wall synthesis. 
